TIMP3 and cancer: In this study, significant downregulation of TIMP3 was detected in several cancer types, such as lung adenocarcinoma (LUAD), kidney chromophobe (KICH), lung squamous cell carcinoma (LUSC), and uterine carcinosarcoma (UCS) tissues, in addition to CRC.